-
2
-
-
0035282334
-
Mammalian MAP kinase signalling cascades
-
DOI 10.1038/35065000
-
Chang L and Karin M: Mammalian MAP kinase signalling cascades. Nature 410: 37-40, 2001. (Pubitemid 32225829)
-
(2001)
Nature
, vol.410
, Issue.6824
, pp. 37-40
-
-
Chang, L.1
Karin, M.2
-
3
-
-
0035805596
-
Akt, MAPK (Erk1/2) and p38 act in concert to promote apoptosis in response to Erb2 receptor family inhibition
-
Nelson JM and Fry DW: Akt, MAPK (Erk1/2) and p38 act in concert to promote apoptosis in response to Erb2 receptor family inhibition. J Biol Chem 276: 14842-14847, 2001.
-
(2001)
J Biol Chem
, vol.276
, pp. 14842-14847
-
-
Nelson, J.M.1
Fry, D.W.2
-
4
-
-
5044228741
-
Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation
-
DOI 10.1210/me.2004-0082
-
Steinmetz R, Wagoner HA, Zeng P, Hammond JR, Hannon TS, Meyers JL and Pescovitz OH: Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation. Mol Endocrinol 18: 2570-2582, 2004. (Pubitemid 39335989)
-
(2004)
Molecular Endocrinology
, vol.18
, Issue.10
, pp. 2570-2582
-
-
Steinmetz, R.1
Wagoner, H.A.2
Zeng, P.3
Hammond, J.R.4
Hannon, T.S.5
Meyers, J.L.6
Pescovitz, O.H.7
-
5
-
-
77956510367
-
Role of extracellular signal-regulated kinase (ERK) 1/2 in multicellular resistance to docetaxel in MCF-7 cells
-
Jeong EK, Lee SY, Jeon HM, Ju MK, Kim CH and Kang HS: Role of extracellular signal-regulated kinase (ERK) 1/2 in multicellular resistance to docetaxel in MCF-7 cells. Int J Oncol 37: 655-661, 2010.
-
(2010)
Int J Oncol
, vol.37
, pp. 655-661
-
-
Jeong, E.K.1
Lee, S.Y.2
Jeon, H.M.3
Ju, M.K.4
Kim, C.H.5
Kang, H.S.6
-
6
-
-
78650621692
-
Small-molecule inhibitors of the ERK signaling pathway: Towards novel anticancer therapeutics
-
Yap JL, Worlikar S, MacKerell AD Jr., Shapiro P and Fletcher S: Small-molecule inhibitors of the ERK signaling pathway: Towards novel anticancer therapeutics. ChemMedChem 6: 38-48, 2011.
-
(2011)
ChemMedChem
, vol.6
, pp. 38-48
-
-
Yap, J.L.1
Worlikar, S.2
MacKerell Jr., A.D.3
Shapiro, P.4
Fletcher, S.5
-
7
-
-
79952109693
-
From the bench to the bed side: PI3K pathway inhibitors in clinical development
-
Maira SM, Finan P and Garcia-Echeverria C: From the bench to the bed side: PI3K pathway inhibitors in clinical development. Curr Top Microbiol Immunol 347: 209-239, 2010.
-
(2010)
Curr Top Microbiol Immunol
, vol.347
, pp. 209-239
-
-
Maira, S.M.1
Finan, P.2
Garcia-Echeverria, C.3
-
8
-
-
0025218139
-
In vivo antitumor activity of 9-[(2-phosphonylmethoxy)ethyl]guanine and related phosphonate nucleotide analogues
-
Rose WC, Crosswell AR, Bronson JJ and Martin JC: In vivo antitumor activity of 9-[(2-phosphonylmethoxy)ethyl]-guanine and related phosphonate nucleotide analogues. J Natl Cancer Inst 82: 510-512, 1990. (Pubitemid 20108055)
-
(1990)
Journal of the National Cancer Institute
, vol.82
, Issue.6
, pp. 510-512
-
-
Rose, W.C.1
Crosswell, A.R.2
Bronson, J.J.3
Martin, J.C.4
-
9
-
-
0034052289
-
Anticancer effect of PMEDAP-monitoring of apoptosis
-
Bobková K, Otová B, Marinov I, Mandys V, Panczak A, Votruba I and Holy A: Anticancer effect of PMEDAP-monitoring of apoptosis. Anticancer Res 20: 1041-1047, 2000.
-
(2000)
Anticancer Res
, vol.20
, pp. 1041-1047
-
-
Bobková, K.1
Otová, B.2
Marinov, I.3
Mandys, V.4
Panczak, A.5
Votruba, I.6
Holy, A.7
-
10
-
-
66649100502
-
Targeting DNA repair in chronic lymphocytic leukemia cells with a novel acyclic nucleotide analogue, GS-9219
-
Tsai CY, Ray AS, Tumas DB, Keating MJ, Reiser H and Plunkett W: Targeting DNA repair in chronic lymphocytic leukemia cells with a novel acyclic nucleotide analogue, GS-9219. Clin Cancer Res 15: 3760-3769, 2009.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3760-3769
-
-
Tsai, C.Y.1
Ray, A.S.2
Tumas, D.B.3
Keating, M.J.4
Reiser, H.5
Plunkett, W.6
-
11
-
-
66149168682
-
Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma
-
Vail DM, Thamm DH, Reiser H, Ray AS, Wolfgang GH, Watkins WJ, Babusis D, Henne IN, Hawkins MJ, Kurzman ID, Jeraj R, Vanderhoek M, Plaza S, Anderson C, Wessel MA, Robat C, Lawrence J and Tumas DB: Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma. Clin Cancer Res 15: 3503-3510, 2009.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3503-3510
-
-
Vail, D.M.1
Thamm, D.H.2
Reiser, H.3
Ray, A.S.4
Wolfgang, G.H.5
Watkins, W.J.6
Babusis, D.7
Henne, I.N.8
Hawkins, M.J.9
Kurzman, I.D.10
Jeraj, R.11
Vanderhoek, M.12
Plaza, S.13
Anderson, C.14
Wessel, M.A.15
Robat, C.16
Lawrence, J.17
Tumas, D.B.18
-
12
-
-
0025372944
-
Acyclic nucleotide analogues: Synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro
-
DOI 10.1016/0166-3542(90)90014-X
-
Holý A, Votruba I, Merta A, Černý J, Veselý J, Vlach J, Šedivá K, Rosenberg I, Otmar M, Hř ebabecký H et al: Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro. Antiviral Res 13: 295-311, 1990. (Pubitemid 20223544)
-
(1990)
Antiviral Research
, vol.13
, Issue.6
, pp. 295-311
-
-
Holy, A.1
Votruba, I.2
Merta, A.3
Cerny, J.4
Vesely, J.5
Vlach, J.6
Sediva, K.7
Rosenberg, I.8
Otmar, M.9
Hrebabecky, H.10
Travnicek, M.11
Vonka, V.12
Snoeck, R.13
De Clercq, E.14
-
13
-
-
1542285510
-
Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells
-
DOI 10.1016/j.bbrc.2004.02.017, PII S0006291X04002621
-
Habiro A, Tanno S, Koizumi K, Izawa T, Nakano Y, Osanai M, Mizukami Y, Okumura T and Kohgo Y: Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells. Biochem Biophys Res Commun 316: 71-77, 2004. (Pubitemid 38299130)
-
(2004)
Biochemical and Biophysical Research Communications
, vol.316
, Issue.1
, pp. 71-77
-
-
Habiro, A.1
Tanno, S.2
Koizumi, K.3
Izawa, T.4
Nakano, Y.5
Osanai, M.6
Mizukami, Y.7
Okumura, T.8
Kohgo, Y.9
-
14
-
-
0029941879
-
Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta, and epsilon
-
Kramata P, Votruba I, Otová B and Holy A: Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon. Mol Pharmacol 49: 1005-1011, 1996. (Pubitemid 26182989)
-
(1996)
Molecular Pharmacology
, vol.49
, Issue.6
, pp. 1005-1011
-
-
Kramata, P.1
Votruba, I.2
Otova, B.3
Holy, A.4
-
15
-
-
77955781919
-
Role of caspases and CD95/FAS in the apoptotic effects of a nucleotide analog PMEG in CCRF-CEM cells
-
Mertlíková-Kaiserová H, Votruba I, Matoušová M, Holý A and Hájek M: Role of caspases and CD95/FAS in the apoptotic effects of a nucleotide analog PMEG in CCRF-CEM cells. Anticancer Res 30: 2791-2798, 2010.
-
(2010)
Anticancer Res
, vol.30
, pp. 2791-2798
-
-
Mertlíková-Kaiserová, H.1
Votruba, I.2
Matoušová, M.3
Holý, A.4
Hájek, M.5
-
16
-
-
0031793432
-
A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase
-
Fox T, Coll JT, Xie X, Ford PJ, Germann UA, Porter MD, Pazhanisamy S, Fleming MA, Galullo V, Su MS and Wilson KP: A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase. Protein Sci 7: 2249-2255, 1998. (Pubitemid 28506941)
-
(1998)
Protein Science
, vol.7
, Issue.11
, pp. 2249-2255
-
-
Fox, T.1
Coll, J.T.2
Xie, X.3
Ford, P.J.4
Germann, U.A.5
Porter, M.D.6
Pazhanisamy, S.7
Fleming, M.A.8
Galullo, V.9
Su, M.S.S.10
Wilson, K.P.11
|